Stelara 90 MG/ML syringeml
Ended Awarded Last action
- Contract number
- SPE2DR26FGET2
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,584
Award facts
- Contract value 100% obligated
- $16,584.13 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,584.13 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/mL syringes. This firm fixed-price delivery order, issued on January 28, 2026, with an ultimate completion date of February 19, 2026, carries no set-aside designation, indicating the award was made through full and open competition. The contract was funded by DLA and will be performed at the contractor's Park Ridge facility.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion governmentwide acquisition strategy designed to streamline pharmaceutical supply to Department of Defense medical facilities worldwide. The parent contract, valued at $499,999,999 with a completion date of December 31, 2036, authorizes DLA to issue delivery orders for branded and generic pharmaceuticals, biologics, and medical consumables to support military healthcare operations globally. DMS Pharmaceutical Group serves as a critical regional prime vendor contractor within this strategic initiative and has demonstrated substantial federal contracting performance across diverse therapeutic categories and product lines.
Quick answers
Who was awarded contract SPE2DR26FGET2?
SPE2DR26FGET2 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26FGET2 worth?
The government has obligated $16,584 on SPE2DR26FGET2.
Is contract SPE2DR26FGET2 an order under another contract?
Yes. SPE2DR26FGET2 is a delivery order under SPE2DR25D9312, an indefinite delivery contract.
Was contract SPE2DR26FGET2 competed?
The extent of competition for SPE2DR26FGET2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award